Wells Fargo & Company Novavax Inc Put Options Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
Put Options
2 transactions
Others Institutions Holding NVAX
# of Institutions
299Shares Held
90MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$110 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$83.3 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$78.3 Million33.15% of portfolio
-
State Street Corp Boston, MA7.04MShares$49.5 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$27 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $550M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...